Clinical Trial

Harnessing Optimism and Perseverance in the Face of Long COVID-Español

Study acronym: HOPE-LC
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The Harnessing Optimism and Perseverance in the Face of Long COVID (HOPE-LC) program, created by Drs. Eric Watson and Amelia Hicks, is a group therapy model designed to foster resilience, adjustment, and coping skills for those living with chronic Long COVID. HOPE-LC\~Español provides a culturally and linguistically adapted version for Spanish-speaking individuals in Queens, developed with input from Spanish-speaking clinicians, Long COVID experts, and people with lived experience. Partnering with H+H/Elmhurst and H+H/Queens, the project aims to recruit 25 participants and evaluate program feasibility and preliminary efficacy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-10-09.
Trial Details
NCT Number NCT07216040
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions Post-Acute COVID-19 Syndrome
Enrollment 25 participants
Start Date 2026-05
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-23